Literature DB >> 21339722

An orthotopic model of murine bladder cancer.

Georgina L Dobek1, W T Godbey.   

Abstract

In this straightforward procedure, bladder tumors are established in female C57 mice through the use of catheterization, local cauterization, and subsequent cell adhesion. After their bladders are transurethrally catheterized and drained, animals are again catheterized to permit insertion of a platinum wire into bladders without damaging the urethra or bladder. The catheters are made of Teflon to serve as an insulator for the wire, which will conduct electrical current into the bladder to create a burn injury. An electrocautery unit is used to deliver 2.5W to the exposed end of the wire, burning away extracellular layers and providing attachment sites for carcinoma cells that are delivered in suspension to the bladder through a subsequent catheterization. Cells remain in the bladder for 90 minutes, after which the catheters are removed and the bladders allowed to drain naturally. The development of tumor is monitored via ultrasound. Specific attention is paid to the catheterization technique in the accompanying video.

Entities:  

Mesh:

Year:  2011        PMID: 21339722      PMCID: PMC3197410          DOI: 10.3791/2535

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  2 in total

1.  Optimizing syngeneic orthotopic murine bladder cancer (MB49).

Authors:  J H Günther; A Jurczok; T Wulf; S Brandau; I Deinert; D Jocham; A Böhle
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

2.  Expression-targeted gene therapy for the treatment of transitional cell carcinoma.

Authors:  X Zhang; A Atala; W T Godbey
Journal:  Cancer Gene Ther       Date:  2008-03-07       Impact factor: 5.987

  2 in total
  16 in total

1.  An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment.

Authors:  Moo Rim Kang; Glen Yang; Klaus Charisse; Hila Epstein-Barash; Muthiah Manoharan; Long-Cheng Li
Journal:  J Vis Exp       Date:  2012-07-28       Impact factor: 1.355

2.  Analysis of promoters and expression-targeted gene therapy optimization based on doubling time and transfectability.

Authors:  Georgina L Dobek; Xiujuan Zhang; Daniel A Balazs; W T Godbey
Journal:  FASEB J       Date:  2011-05-20       Impact factor: 5.191

3.  Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.

Authors:  Peter A Raven; Ninadh M D'Costa; Igor Moskalev; Zheng Tan; Sebastian Frees; Claudia Chavez-Munoz; Alan I So
Journal:  Am J Clin Exp Urol       Date:  2018-12-20

Review 4.  Modelling bladder cancer in mice: opportunities and challenges.

Authors:  Takashi Kobayashi; Tomasz B Owczarek; James M McKiernan; Cory Abate-Shen
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

5.  A Murine Orthotopic Bladder Tumor Model and Tumor Detection System.

Authors:  Sin Mun Tham; Kesavan Esuvaranathan; Ratha Mahendran
Journal:  J Vis Exp       Date:  2017-01-12       Impact factor: 1.355

6.  Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer.

Authors:  Shingo Tsuji; Katherine Reil; Kinsey Nelson; Veronica H Proclivo; Kathleen L McGuire; Matthew J Giacalone
Journal:  Cancer Immunol Res       Date:  2022-08-03       Impact factor: 12.020

7.  An orthotopic bladder cancer model for gene delivery studies.

Authors:  Laura Kasman; Christina Voelkel-Johnson
Journal:  J Vis Exp       Date:  2013-12-01       Impact factor: 1.355

8.  Animal models for bladder cancer: The model establishment and evaluation (Review).

Authors:  Ning Zhang; Dongyang Li; Jialiang Shao; Xiang Wang
Journal:  Oncol Lett       Date:  2015-01-23       Impact factor: 2.967

9.  Minimally invasive establishment of murine orthotopic bladder xenografts.

Authors:  Wolfgang Jäger; Igor Moskalev; Claudia Janssen; Tetsutaro Hayashi; Killian M Gust; Shannon Awrey; Peter C Black
Journal:  J Vis Exp       Date:  2014-02-11       Impact factor: 1.355

10.  An essential role for decorin in bladder cancer invasiveness.

Authors:  Mohamed El Behi; Sophie Krumeich; Catalina Lodillinsky; Aurélie Kamoun; Lorenzo Tibaldi; Gaël Sugano; Aurélien De Reynies; Elodie Chapeaublanc; Agnès Laplanche; Thierry Lebret; Yves Allory; François Radvanyi; Olivier Lantz; Ana María Eiján; Isabelle Bernard-Pierrot; Clotilde Théry
Journal:  EMBO Mol Med       Date:  2013-10-20       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.